MODULE – 27

Dr. Manjunath J V shares that Seborrheic dermatitis is a common chronic inflammatory skin condition that significantly impacts patients’ quality of life. A deeper understanding of its pathophysiology, including the role of skin barrier dysfunction, immune dysregulation, and Malassezia yeast, has enhanced our approach to diagnosis and management. While conventional antifungal and anti-inflammatory therapies remain the cornerstone of treatment, emerging therapeutic options are offering more targeted and long-term disease control. As dermatologists, staying updated on these advances is essential to optimize patient outcomes and provide individualized care